Exencial Wealth Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.1M Sell
7,869
-291
-4% -$78.8K 0.07% 219
2025
Q4
$2.05M Sell
8,160
-159
-2% -$42.2K 0.06% 221
2025
Q3
$2.39M Sell
8,319
-58
-0.7% -$15.5K 0.08% 199
2025
Q2
$2.2M Sell
8,377
-484
-5% -$118K 0.08% 204
2025
Q1
$2.06M Sell
8,861
-188
-2% -$45.6K 0.08% 209
2024
Q4
$2.08M Sell
9,049
-503
-5% -$115K 0.08% 205
2024
Q3
$2.13M Sell
9,552
-508
-5% -$112K 0.08% 207
2024
Q2
$2.05M Sell
10,060
-1,013
-9% -$206K 0.08% 207
2024
Q1
$2.42M Sell
11,073
-426
-4% -$93.8K 0.09% 192
2023
Q4
$2.61M Sell
11,499
-275
-2% -$57.8K 0.11% 177
2023
Q3
$2.37M Sell
11,774
-2,351
-17% -$496K 0.11% 161
2023
Q2
$2.93M Buy
14,125
+1,061
+8% +$206K 0.13% 152
2023
Q1
$2.57M Buy
13,064
+537
+4% +$111K 0.13% 155
2022
Q4
$2.53M Buy
12,527
+1,417
+13% +$277K 0.14% 159
2022
Q3
$1.96M Buy
11,110
+277
+3% +$56.7K 0.12% 163
2022
Q2
$2.18M Sell
10,833
-33
-0.3% -$7.03K 0.12% 164
2022
Q1
$2.46M Buy
10,866
+122
+1% +$28.7K 0.12% 171
2021
Q4
$2.9M Buy
10,744
+374
+4% +$92.6K 0.14% 165
2021
Q3
$2.51M Buy
10,370
+3,585
+53% +$903K 0.11% 135
2021
Q2
$1.61M Sell
6,785
-1,157
-15% -$264K 0.09% 199
2021
Q1
$1.74M Buy
7,942
+1,499
+23% +$301K 0.1% 180
2020
Q4
$1.13M Sell
6,443
-7,914
-55% -$1.37M 0.08% 190
2020
Q3
$2.32M Buy
14,357
+7,989
+125% +$1.27M 0.12% 162
2020
Q2
$909K Buy
+6,368
New +$881K 0.08% 184

Other funds holding LH

Exencial Wealth Advisors's LH Position: Q1 2026 in Review

Exencial Wealth Advisors reduced its Labcorp (LH) stake by 3.6% in Q1 2026, selling an estimated $78.8K and leaving 7,869 shares worth $2.1M. The position accounts for 0.07% of the portfolio, ranked #219.

Exencial Wealth Advisors first reported a position in LH in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.93M in Q2 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Exencial Wealth Advisors held 7,869 shares of Labcorp worth $2.1M as of Q1 2026.
  • Exencial Wealth Advisors sold 291 Labcorp shares in Q1 2026, an estimated $78.8K.
  • Labcorp made up 0.07% of Exencial Wealth Advisors's portfolio in Q1 2026, its #219 holding.
  • Exencial Wealth Advisors first reported a position in Labcorp in Q2 2020 and has held it in 24 quarters since.
  • Exencial Wealth Advisors's Labcorp position peaked at $2.93M in Q2 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.